ICD-10-CM Billable Code

G25.7

Other and unspecified drug induced movement disorders

Clinical Classification Guidelines

Use Additional Code

  • code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)

Medical Intelligence & Overview

ICD-10 code G25.7 refers to a category of movement disorders caused by adverse reactions to medications. These disorders can significantly impact daily life and vary widely in presentation and severity. This condition encompasses a range of movement abnormalities triggered by different drugs, making diagnosis and management a challenge. Recognizing the signs and understanding potential causes can help in seeking appropriate medical attention.

Causes & Symptoms

Clinical Causes: Use of antipsychotic medications, especially those known to block dopamine receptors Certain antidepressants and mood stabilizers Medications used for nausea, such as dopamine antagonists Drugs for Parkinson's disease, which can sometimes induce unwanted movements Over-the-counter and herbal supplements with active ingredients affecting motor control Polypharmacy, where multiple medications interact to provoke movement issues

Key Symptoms: Involuntary movements, such as tremors, jerks, or muscle spasms Facial grimacing or twitching Restlessness or an inability to stay still Uncontrolled movements of limbs or trunk Tardive dyskinesia, characterized by repetitive, involuntary movements in the face and mouth Atypical muscle rigidity or dystonia Difficulty initiating voluntary movements

Diagnostic & Treatment

Diagnosis Path: Diagnosing drug-induced movement disorders involves a thorough review of the patient's medication history and a physical examination. Healthcare providers often look for new or worsening movement symptoms correlating with the initiation or dosage change of a medication. Diagnostic tests, such as neuroimaging or blood tests, may be used to rule out other neurological conditions. The key criterion is the temporal relationship between medication use and symptom onset, along with improvement upon discontinuation or adjustment of the suspected drug.

Treatment Protocols: Discontinuing or adjusting the offending medication under medical supervision, if possible Switching to alternative drugs with a lower risk of movement side effects Use of medications to reduce symptoms, such as anticholinergic agents or benzodiazepines Implementing supportive therapies like physical therapy to improve mobility and reduce discomfort Monitoring for symptom recurrence or worsening with any medication changes

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is G25.7 a billable ICD-10 code?
Yes, G25.7 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report G25.7?
Clinical documentation must specify the nature of Other and unspecified drug induced movement disorders and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

induced disorders movement